Literature DB >> 19953647

Ifosfamide-induced encephalopathy and movement disorder.

Bethany Ames1, Lionel D Lewis, Sara Chaffee, Julie Kim, Richard Morse.   

Abstract

Ifosfamide is a widely used chemotherapeutic agent for the treatment of a broad spectrum of solid tumors. CNS toxicity is a well-described side effect of ifosfamide, but the mechanism of ifosfamide-induced neurotoxicity remains poorly defined. We present two pediatric cases of hemiballismic limb movements in the setting of ifosfamide-associated encephalopathy. To our knowledge, there have been no prior reports of ifosfamide-induced hemiballism in pediatric patients. One of our patient's encephalopathy and abnormal movements may have improved after the administration of methylene blue and thiamine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19953647     DOI: 10.1002/pbc.22361

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  9 in total

1.  Green urine secondary to methylene blue.

Authors:  Ghasem Miri-Aliabad
Journal:  Indian J Pediatr       Date:  2014-05-04       Impact factor: 1.967

2.  Ifosfamide associated myoclonus-encephalopathy syndrome.

Authors:  Rodolfo Savica; Alejandro A Rabinstein; Keith A Josephs
Journal:  J Neurol       Date:  2011-03-12       Impact factor: 4.849

Review 3.  Role of inflammation and oxidative stress in chemotherapy-induced neurotoxicity.

Authors:  Pooja Gupta; Tavneet Kaur Makkar; Lavisha Goel; Monika Pahuja
Journal:  Immunol Res       Date:  2022-07-20       Impact factor: 4.505

Review 4.  Chemotherapy-Related Neurotoxicity.

Authors:  Sophie Taillibert; Emilie Le Rhun; Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2016-09       Impact factor: 5.081

Review 5.  The glycine deportation system and its pharmacological consequences.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  Pharmacol Ther       Date:  2012-05-11       Impact factor: 12.310

Review 6.  Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell Transplantation.

Authors:  Duccio Maria Cordelli; Riccardo Masetti; Daniele Zama; Francesco Toni; Ilaria Castelli; Emilia Ricci; Emilio Franzoni; Andrea Pession
Journal:  Front Pediatr       Date:  2017-05-15       Impact factor: 3.418

Review 7.  Review: Neurological Complications From Therapies for Pediatric Brain Tumors.

Authors:  Thien Nguyen; Sabine Mueller; Fatema Malbari
Journal:  Front Oncol       Date:  2022-04-11       Impact factor: 5.738

8.  Downregulation of oxidative and nitrosative apoptotic signaling by L-carnitine in Ifosfamide-induced Fanconi syndrome rat model.

Authors:  Mohamed M Sayed-Ahmed; Mohamed M Hafez; Meshan Lafi Aldelemy; Abdulaziz M Aleisa; Salem S Al-Rejaie; Khaled A Al-Hosaini; Naif O Al-Harbi; Mohamed M Al-Harbi; Othman A Al-Shabanah
Journal:  Oxid Med Cell Longev       Date:  2012-11-13       Impact factor: 6.543

9.  Linking vitamin B1 with cancer cell metabolism.

Authors:  Jason A Zastre; Rebecca L Sweet; Bradley S Hanberry; Star Ye
Journal:  Cancer Metab       Date:  2013-07-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.